Outremont, Canada

Chris M Farnet

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 1 EPO patent. Top assignees: Thallion Pharmaceuticals Inc., Ecopia Biosciences, Inc., Boehringer Ingelheim (Canada) Ltd.. Active years: 2001-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chris M Farnet. Retrieved from https://idiyas.com/inventor/chris-m-farnet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 11.8

 


Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 48(Granted Patents)


Location History:

  • Montreal, CA (2007 - 2008)
  • Montréal, CA (2008)
  • Outremont, CA (2001 - 2009)

Company Filing History:


Years Active: 2001-2009

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Chris M Farnet: Innovator in Antibiotic Development

Introduction

Chris M Farnet is a prominent inventor based in Outremont, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of antibiotics. With a total of 17 patents to his name, Farnet's work has had a substantial impact on pharmaceutical research and development.

Latest Patents

Farnet's latest patents include groundbreaking inventions such as the gene encoding a nonribosomal peptide synthetase for the production of ramoplanin. This invention relates to isolated genetic sequences that direct the biosynthesis of the antibiotic ramoplanin in microorganisms. The isolated gene sequences serve as substrates for bioengineering antibiotic structures. Another notable patent is for farnesyl dibenzodiazepinone and processes for its production. This invention involves a novel farnesylated dibenzodiazepinone, named ECO-04601, along with its pharmaceutically acceptable salts and derivatives. The methods for obtaining ECO-04601 include the cultivation of a novel strain of microorganisms and the expression of biosynthetic pathway genes in transformed host cells. This invention also relates to the use of ECO-04601 as a pharmaceutical, particularly as an inhibitor of cancer cell growth and bacterial cell growth.

Career Highlights

Throughout his career, Farnet has worked with notable companies such as Thallion Pharmaceuticals Inc. and Ecopia Biosciences, Inc. His work in these organizations has contributed to advancements in drug development and biotechnology.

Collaborations

Farnet has collaborated with esteemed colleagues, including Emmanuel Zazopoulos and Alfredo Staffa. These partnerships have fostered innovation and have been instrumental in the success of his projects.

Conclusion

Chris M Farnet is a distinguished inventor whose work in antibiotic development has made a lasting impact on the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to advancing biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…